glp 1 and muscle mass loss Biolinq's biosensor tracks during GLP-1 therapy | Biolinq posted on the topic 1/2) New research suggests GLP-1
Description
J Med Case Rep

The main difference lies in how they are used: the Wegovy injection is administered once weekly, while the Wegovy tablet is intended for daily oral intake

In particular, it was suggested that GLP-1 may increase potassium-ATP currents, thereby increasing membrane potential of smooth muscle cells and preventing depolarization and contraction (Xiong et al., 2019)
Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus treatment

Your healthcare team will provide clear instructions for these situations